Erlotinib Completed Phase 1 Trials for Head and Neck Carcinoma / Stage IV Head and Neck Cancer / Parotid Gland Cancer / Melanoma / Thyroid neoplasms malignant / Malignant Neoplasm of Thyroid Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00405405Phase I of Biologics and Chemoradiation Therapy for Advanced Head and Neck Cancer
NCT00113347Erlotinib and Docetaxel With Concomitant Boost Radiation Therapy (XRT) for Head and Neck Squamous Cell Carcinoma (HNSCC)
NCT00079053Adjuvant Erlotinib After Completing Chemoradiotherapy in Treating Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck